STAAR Surgical (NASDAQ:STAA) Shares Sold by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. reduced its position in shares of STAAR Surgical (NASDAQ:STAA) by 1.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 426,122 shares of the medical instruments supplier’s stock after selling 4,521 shares during the period. Charles Schwab Investment Management Inc. owned 0.86% of STAAR Surgical worth $15,830,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Van ECK Associates Corp boosted its stake in STAAR Surgical by 12.7% during the third quarter. Van ECK Associates Corp now owns 3,478 shares of the medical instruments supplier’s stock worth $129,000 after buying an additional 393 shares during the period. Sei Investments Co. boosted its stake in STAAR Surgical by 2.7% during the second quarter. Sei Investments Co. now owns 15,087 shares of the medical instruments supplier’s stock worth $718,000 after buying an additional 394 shares during the period. Creative Planning boosted its stake in STAAR Surgical by 8.0% during the third quarter. Creative Planning now owns 5,524 shares of the medical instruments supplier’s stock worth $205,000 after buying an additional 408 shares during the period. Wealth Enhancement Advisory Services LLC boosted its stake in STAAR Surgical by 3.8% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 11,343 shares of the medical instruments supplier’s stock worth $540,000 after buying an additional 418 shares during the period. Finally, Louisiana State Employees Retirement System boosted its stake in STAAR Surgical by 2.1% during the second quarter. Louisiana State Employees Retirement System now owns 24,700 shares of the medical instruments supplier’s stock worth $1,176,000 after buying an additional 500 shares during the period. 96.70% of the stock is currently owned by institutional investors and hedge funds.

STAAR Surgical Stock Performance

NASDAQ STAA opened at $25.31 on Friday. The firm has a 50 day simple moving average of $29.90 and a 200-day simple moving average of $35.53. STAAR Surgical has a one year low of $25.04 and a one year high of $52.68. The firm has a market cap of $1.25 billion, a price-to-earnings ratio of 57.52 and a beta of 0.59.

Wall Street Analyst Weigh In

Several brokerages have weighed in on STAA. Needham & Company LLC reaffirmed a “hold” rating on shares of STAAR Surgical in a research note on Thursday, October 31st. Canaccord Genuity Group lowered their target price on shares of STAAR Surgical from $41.00 to $31.00 and set a “hold” rating for the company in a research note on Friday, November 1st. Stifel Nicolaus lowered their target price on shares of STAAR Surgical from $50.00 to $44.00 and set a “buy” rating for the company in a research note on Monday, August 26th. Finally, Stephens raised shares of STAAR Surgical to a “hold” rating in a research note on Monday, December 2nd. One analyst has rated the stock with a sell rating, four have issued a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, STAAR Surgical has an average rating of “Hold” and an average target price of $43.33.

STAAR Surgical Company Profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.